Latest news with #DaniellaParra
Yahoo
3 days ago
- Business
- Yahoo
Grove Collaborative Posts Drop in 2Q Revenue But Bullish Outlook
By Daniella Parra Grove Collaborative Holdings, Inc. (NYSE: GROV) said second quarter revenue reached $44.0 million, down 15.5% year-over-year but up 1.1% from the prior quarter. The company posted a net loss of $3.6 million, compared to net loss of $10.1 million in same period last year and adjusted EBITDA of $(0.9) million, compared to $1.1 million last year. Gross Margin was 55.4%, an improvement of 150 basis points, Grove said. 'At Grove, we remain focused on building the leading marketplace of curated, clean and sustainable products for conscientious consumers—a platform defined by trust, rigorous standards, and a deep commitment to sustainability and personal wellness,' Jeff Yurcisin, Chief Executive Office of Grove Collaborative, said. 'While the second quarter brought both progress and setbacks as we navigated challenges from our eCommerce platform migration, we saw encouraging signs of recovery, including sequential revenue and order growth.' See More: Abacus Global Management Delivers Strong Q2 Earnings, Upgrades FY Outlook Contact: Exec Edge Editor@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
21-07-2025
- Business
- Yahoo
Harry Upcott Joins Vinson & Elkins to Drive Aviation Finance Expansion in Europe
By Daniella Parra Vinson & Elkins has expanded its global aviation finance practice with the addition of Harry Upcott as a partner in its London office, it said. Upcott brings extensive experience advising on complex aviation and satellite financing, leasing, and M&A deals, and is recognized for his commercially practical approach, the law firm said. 'Vinson & Elkins has a clear focus on building a strong international platform in aviation finance,' Vinson & Elkins Partner Harry Upcott said. 'The firm's integrated capabilities across finance, capital markets and restructuring provide a market-leading platform for supporting clients in this dynamic sector.' READ MORENever Miss an Insight, Our Newsletter Contact: Exec Edge Editor@ Click to follow us on LinkedIn
Yahoo
08-07-2025
- Business
- Yahoo
GameSquare Unveils $100M Ethereum Strategy, Raises $8M in Public Offering
By Daniella Parra GameSquare Holdings (NASDAQ: GAME) said it's launching a crypto-focused treasury strategy backed by a strategic alliance with Dialectic, aiming to generate on-chain yields of 8–14% using Ethereum. The company's board approved up to $100 million in ETH investments over time, it said. GameSquare raised $8 million through a public offering of 8.4 million shares at $0.95 each and proceeds will fund the Ethereum strategy, powered by Dialectic's Medici platform, which leverages AI and risk controls for yield optimization, it said. 'Today's announcement reflects the confidence of a proven group of high-quality investors and leaders in decentralized finance,' said Justin Kenna, CEO of GameSquare. 'We've partnered with one of the world's top crypto investment firms to generate real, on-chain yield while deepening our expertise in decentralized finance, pursuing new revenue streams, and strengthening our balance sheet.' READ MORE GameSquare Steps Up Crypto Strategy Through Dialectic Partnership Register for our weekly newsletter Contact: Exec Edge Editor@ Click to follow us on LinkedIn Errore nel recupero dei dati Effettua l'accesso per consultare il tuo portafoglio Errore nel recupero dei dati Errore nel recupero dei dati Errore nel recupero dei dati Errore nel recupero dei dati
Yahoo
13-06-2025
- Health
- Yahoo
Study Confirms SKY92 Test Improves Multiple Myeloma Risk Assessment
By Daniella Parra A new study published in the British Journal of Haematology confirms that the SKY92 gene expression profiling test significantly enhances risk stratification in multiple myeloma patients, outperforming traditional clinical markers, SkylineDx said. Risk stratification by SKY92 showed significant differences in survival end points, with SKY92 standard-risk patients having a 3-year PFS and OS of 66% and 92% while SKY92 high-risk patients have a 3-year PFS and OS of 39% and 76% respectively, they said. 'This publication confirms years of scientific work and collaboration,' said Jvalini Dwarkasing, PhD, Chief Scientific Officer at SkylineDx. 'The SKY92 signature brings molecular precision to the clinic, giving physicians a powerful tool to reduce uncertainty in a highly complex disease. It's incredibly rewarding to see its positive impact on real-world patient care'. Contact: Exec Edge Editor@
Yahoo
21-05-2025
- Business
- Yahoo
Jeito Capital Leads $65M Series A to Advance Innovations in Reproductive Medicine
By Daniella Parra Jeito Capital said it led a $65 million Series A funding round in ReproNovo, a biotech company focused on reproductive medicine and women's health/. ReproNovo is addressing male and female infertility and uterine health advancing in RPN-001, an oral treatment for male infertility linked to low testosterone and RPN-002, a first-in-class oral treatment for adenomyosis and improving outcomes in assisted reproductive technologies. 'As approximately one in six people worldwide will face infertility issues, we are proud to support ReproNovo, whose commitment to advancing novel therapies in reproductive health aligns well with our focus on accelerating cutting-edge technologies and the commercialization of treatments with transformative benefits for patients,' Ksenija Pavletic, Partner and Chief Commercial Officer at Jeito Capital, said. Contact: Editor@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
